Published in Melanoma Res on April 01, 2015
Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors. Clin Exp Metastasis (2015) 0.85
Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis. Mol Cancer (2015) 0.84
Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression. Oncotarget (2015) 0.81
Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells. Oncotarget (2016) 0.79
Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting. Front Pharmacol (2016) 0.78
Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting. Cancer Res (2016) 0.77
Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1). J Med Chem (2015) 0.77
Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma. Mol Cancer (2017) 0.75
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma. Oncotarget (2016) 0.75
High ALDH1 expression correlates with better prognosis in tumorigenic malignant melanoma. Mod Pathol (2017) 0.75
Skin models for the testing of transdermal drugs. Clin Pharmacol (2016) 0.75
ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment. Oncogene (2017) 0.75
Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma. J Clin Oncol (2007) 2.19
Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood (2005) 2.06
CD133 is a marker for long-term repopulating murine epidermal stem cells. J Invest Dermatol (2012) 1.58
Transit-amplifying cell frequency and cell cycle kinetics are altered in aged epidermis. J Invest Dermatol (2009) 1.57
Selection of tumorigenic melanoma cells using ALDH. J Invest Dermatol (2010) 1.27
Evidence that the Pim1 kinase gene is a direct target of HOXA9. Blood (2007) 1.16
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group. J Clin Oncol (2002) 1.15
Trial sequence meta-analysis can reject false-positive result calculated from conventional meta-analysis. Hepatology (2014) 1.06
Predictors of esophageal varices in patients with HBV-related cirrhosis: a retrospective study. BMC Gastroenterol (2009) 1.04
HOXA9 regulates miR-155 in hematopoietic cells. Nucleic Acids Res (2010) 0.94
Imiquimod-induced interleukin-1 alpha stimulation improves barrier homeostasis in aged murine epidermis. J Invest Dermatol (2004) 0.94
Rapid adhesion to collagen isolates murine keratinocytes with limited long-term repopulating ability in vivo despite high clonogenicity in vitro. Stem Cells (2007) 0.88
Prognostic value of lateral lymph node metastasis for advanced low rectal cancer. World J Gastroenterol (2007) 0.87
Melatonin attenuates acute pancreatitis-associated lung injury in rats by modulating interleukin 22. World J Gastroenterol (2012) 0.85
Tiers of clonal organization in the epidermis: the epidermal proliferation unit revisited. Stem Cell Rev (2008) 0.85
The aged epidermal permeability barrier: basis for functional abnormalities. Clin Geriatr Med (2002) 0.84
[The expression of DJ-1 gene in human hepatocellular carcinoma and its relationship with tumor invasion and metastasis]. Zhonghua Gan Zang Bing Za Zhi (2009) 0.82
Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma. Cancer Chemother Pharmacol (2011) 0.82
The CD44+ ALDH+ population of human keratinocytes is enriched for epidermal stem cells with long-term repopulating ability. Stem Cells (2013) 0.82
Murine Sca-1(+)/Lin(-) cells and human KG1a cells exhibit multiple pseudopod morphologies during migration. Exp Hematol (2002) 0.82
[Postoperative detection of AFP mRNA in the peripheral blood of hepatic cellular carcinoma patients and its correlation with recurrence]. Zhonghua Zhong Liu Za Zhi (2007) 0.80
Limiting dilution analysis of murine epidermal stem cells using an in vivo regeneration assay. Methods Mol Biol (2010) 0.79
Docetaxel and vinorelbine plus GM-CSF in malignant melanoma. Oncology (Williston Park) (2005) 0.78
A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology. Cancer Prev Res (Phila) (2014) 0.77
[MDR-reversing effect of two components of catechin on human hepatocellular carcinoma BEL-7404/Adr in vitro]. Ai Zheng (2004) 0.77
[Correlations of genetic polymorphisms of tumor necrosis factor-related apoptosis-inducing ligand gene and its plasma phenotype with ulcerative colitis]. Zhonghua Yi Xue Za Zhi (2012) 0.77
Increased frequency of Foxp3+ regulatory T cells in mice with hepatocellular carcinoma. Asian Pac J Cancer Prev (2012) 0.77
Management of hypertriglyceridemia in patients receiving interferon for malignant melanoma. Ann Pharmacother (2004) 0.76
Cellular automata modeling of FASL-initiated apoptosis. Chem Biodivers (2010) 0.76
Tumor-derived CD4+CD25+ Tregs inhibit the maturation and antigen-presenting function of dendritic cells. Asian Pac J Cancer Prev (2015) 0.76
A new water-based topical carrier with polar skin-lipids. Lipids Health Dis (2006) 0.75
Correlation of fibrinogen-like protein 2 with progression of acute pancreatitis in rats. World J Gastroenterol (2013) 0.75
Study of circumferential resection margin in patients with middle and lower rectal carcinoma. World J Gastroenterol (2007) 0.75
Potential drug-drug interaction between interferon alfa-2b and gemfibrozil in a patient with malignant melanoma. Clin Ther (2005) 0.75
Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma. Cancer Immunol Immunother (2002) 0.75